Tag Archive for: artificial intelligence

IRIS offers immersive insights reports and live dashboards designed to help the healthcare industry and other stakeholders anticipate and identify transformative market events, and how best to strategically navigate the fast-moving environment.

This year, CMI Media Group, a WPP company, and Compas showed an ability to predict and stay ahead of industry trends, according to agency leaders. As the company expanded globally, executives say it also doubled down on AI innovation and omnichannel (which they dubbed “omnidynamic”) strategy.    

By not only tackling high costs but also elevating patient experiences by enhancing efficiency and outcomes, this technology stands ready to revolutionize many aspects of the industry, says GlobalData.

Three core trends emerge as pivotal forces driving the healthcare sector forward: strategic responses to economic uncertainty, the accelerated growth in AI investments, and the groundbreaking advancements in next-generation medications. Together, these trends do not merely represent shifts within the health sector; they signal a critical tipping point, one that demands adaptability, foresight, and an unwavering focus on innovation to navigate the future of health care.

Med Ad News sat down with Ankit Vahia, Ph.D., who recently joined ConcentricLife as chief strategy officer, to talk about the agency’s strategy behind delivering experiences versus having a transactional relationship with clients and brands.

While it’s never actually possible to fully predict the future, we are looking ahead to how artificial intelligence and other emerging technologies – combined with the human touch of professionals – will shape the future of the business of healthcare and pharmaceuticals for generations to come. Before looking at AI’s potential impacts in the space, we must first take stock of the macro trends in healthcare.

Artificial intelligence (AI) is transforming various domains of human activity, including health care. AI can assist in diagnosis, treatment, monitoring, and prevention of diseases, as well as in enhancing the quality and efficiency of health care delivery. However, AI also poses some challenges and risks, such as ethical, legal, and social implications, data privacy and security, and human-AI interaction.

Analyzing social media using artificial intelligence may pick up signals of depression in white Americans but not in Black counterparts, according to a study that highlights the risk of training AI models for healthcare-related tasks without data from diverse racial and ethnic groups.

A consistent theme from SXSW is the downturn of brand advertising. Consumers don’t want to feel marketed to but are open to content that is entertaining or provides some value exchange. Value is not a new concept, as content marketing has been a consistent tactic for a long time. But more often we see consumers’ ability to block or tune out brand content. Couple this with the fact that content looks much different than it did even a few years ago, and it’s clear that this is an area where pharma needs to innovate.

The new offering will help life science and pharmaceutical brands create better and more personalized experiences for both diagnosed and undiagnosed patient populations, accelerating paths to diagnosis and treatment, and creating unmatched educational opportunities. Brand teams will gain unmatched insights into what patient communities are saying and looking for, and then serve up customized content to help them at any stage of the patient journey.